Takeda Pharmaceutical Company Limited Expense Relating To Leases Of Lowvalue Assets For Which Recognition Exemption Has Been Used
Takeda Pharmaceutical Company Limited (TKPHF) reported Expense Relating To Leases Of Lowvalue Assets For Which Recognition Exemption Has Been Used of JPY 493.00 million for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed · last filed 2025-06-25
| Period end | Expense Relating To Leases Of Lowvalue Assets For Which Recognition Exemption Has Been Used 12 month |
|---|---|
| 2025-03-31 | 493.00M JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 887.00M JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 1.25B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 1.30B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 1.25B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 1.56B JPY 20-F · filed 2022-06-29 |